[Study of 3-4-dihydroxyphenylacetic acid, a dopamine catabolite, in patients with Parkinson's disease before treatment with L-dopa].
作者信息
Samson M, Bohuon C, Augustin P, Comoy E, Pouliquen A
出版信息
Rev Neurol (Paris). 1972 Aug;127(2):315-7.
PMID:4666641
Abstract
摘要
相似文献
1
[Study of 3-4-dihydroxyphenylacetic acid, a dopamine catabolite, in patients with Parkinson's disease before treatment with L-dopa].
Rev Neurol (Paris). 1972 Aug;127(2):315-7.
2
3
Plasma 3-0-methyldopa in L-dopa therapy of Parkinson's disease.
Mayo Clin Proc. 1972 Jun;47(6):389-95.
4
Urinary excretion of dopamine and homovanillic acid during L-dopa treatment of Parkinson's disease.帕金森病左旋多巴治疗期间多巴胺和高香草酸的尿排泄情况。
Isr J Med Sci. 1972 May;81(5):597-601.
5
[Biochemistry and treatment of Parkinson's disease].
Laval Med. 1970 Sep;41(7):902-5.
6
L-dopa in Parkinson's disease. A report on 95 cases and review of the literature.
J Med Assoc State Ala. 1971 May;40(11):709-18.
7
[Study of dopamine and noradrenaline in the brains of three patients with Parkinson's disease who died in the course of treatment with L-dopa].
Rev Neurol (Paris). 1972 Aug;127(2):301-2.
8
EEG and urinary non-catecholic amine changes during L-dopa therapy of Parkinson's disease.
Dis Nerv Syst. 1972 Mar;33(3):164-9.
9
Parkinson's syndrome--modern therapy, known facts and unanswered questions.帕金森综合征——现代治疗、已知事实与未解决的问题。
Pharmakopsychiatr Neuropsychopharmakol. 1973 Sep;6(5):229-46. doi: 10.1055/s-0028-1094386.
10
The effect of L-dopa treatment on the speech of patients with Parkinson's disease.
Neurology. 1970 Apr;20(4):410-1.
Zotero 插件